Last updated: July 26, 2026

Application No. 18/546,071

SMTP-7 DERIVATIVE AND USE THEREOF

Non-Final OA

Filed

Aug 10, 2023

Priority

Feb 10, 2021 — CN 202110184080.0 +4 more

Examiner

DEKARSKE, MADELINE MCGUIRE

Art Unit

1622

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Jiangsu Hengrui Pharmaceuticals Co. Ltd.

OA Round

2 (Non-Final)

Examiner Intelligence

DEKARSKE, MADELINE MCGUIRE View full profile →

Grants only 0% of cases

Career Allowance Rate

0 granted / 0 resolved

-60.0% vs TC avg

Minimal +0% lift

Without

With

+0.0%

Interview Lift

resolved cases with interview

Typical timeline

Avg Prosecution

61 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§101

1.0%

-39.0% vs TC avg

§103

46.4%

+6.4% vs TC avg

§102

2.1%

-37.9% vs TC avg

§112

1.0%

-39.0% vs TC avg

Black line = Tech Center average estimate • Based on career data from 0 resolved cases

Prosecution Timeline

Aug 10, 2023

Application Filed

Dec 16, 2025

Non-Final Rejection mailed

Mar 16, 2026

Response Filed

Apr 13, 2026

Final Rejection mailed

Jun 12, 2026

Response after Non-Final Action

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3

Expected OA Rounds

Grant Probability

Moderate

PTA Risk

Based on 0 resolved cases by this examiner. Grant probability derived from career allowance rate.